drugset / Trial / NCT01926821

Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer During Radiation or Chemoradiation Therapy

NCT01926821 ↗

Phase 1 Unknown 200 enrolled Asan Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The impact of sonifilan on the quality of life in patients with cervical cancer during radiation or chemoradiation therapy 1. Primary endpoint : Quality of life 2. Secondary endpoint : complications related to Sonifilan, treatment effect of Sonifilan

Timeline

Start
2013-05
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject SIZOFIRAN Unknown 20 mg Intramuscular

Indications